xintera

  • Stacks Image 68
    Benedicte Lescrauwaet, RN, Msc
    Through my 15-year international career in Outcomes Research & Health Economic (OR&HE) of pharmaceuticals, I have gained hands-on experience in the methodology of pharmacoeconomic evaluation, analysis under uncertainty, non-interventional research, patient reported outcomes, discrete choice experiments, benefit quantification from patient-level data, and support to pricing and reimbursement strategies. I made substantial contributions to the market access approval of the biological Jetrea® in Europa and Spiriva® in Canada.
    Throughout this time, I collaborated with multiple researchers to design, execute and communicate the value proposition of development and in-line products within different therapeutic areas. This allows me to offer you access to a selected network of professionals and knowhow.
  • Stacks Image 64
    Koenraad Blot, MD
    In my 23-year career in pharmaceuticals, I have had the opportunity to work on a wide variety of projects in very different situations. Apart from my work in “big pharma”, I have made substantial contributions to the development and approval of biologicals (Egrifta®, Jetrea®) and to the commercial launch of the first Advanced Therapy Medicinal Product, ChondroCelect®. I have provided feasibility assessments for over 30 generics reformulation/repurposing projects and have had face to face interactions with several Regulatory Agencies including FDA, EMA, MHRA, BfArM, AFFSAPS and AEMPS.